+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Microfluidic Immunoassay Market by Product Type (Lab-on-chip, POC Analyzers, Reagents and Assay), Technology, Application (Cardiac, Troponin, BNP) – Global Forecast to 2025

  • ID: 4841398
  • Report
  • Region: Global
  • 207 Pages
  • Meticulous Market Research Pvt. Ltd.
UP TO OFF
until Dec 31st 2019
1 of 4
Microfluidic Immunoassay Market Worth $2.01 Billion by 2025

FEATURED COMPANIES

  • Abbott Laboratories
  • Biosurfit SA
  • Koninklijke Philips N.V.
  • NanoEnTek Inc.
  • Nanomix Inc.
  • OPKO Health Inc.
  • MORE

The global microfluidic immunoassay market is expected to grow at a CAGR of 12.7% from 2019 to reach $2.0 billion by 2025. The growth in microfluidic immunoassay market is mainly attributed to greater benefits offered by LOC over conventional quantifiable technologies, growing need of POC in low-resource settings, increasing research activities in the field of microfluidic technology, high influx of venture capital funding for the development of LOC-based POC diagnostics, rapid decision making in emergency care, and rising incidence and prevalence of chronic diseases coupled with aging population. In addition, emerging economies and novel technologies such as paper-based microfluidics will further provide significant opportunities for the various stakeholders in this market. However, factors such as lengthy approval time for POC devices and reluctance of healthcare professionals to replace existing diagnostic platforms - are likely to hinder the market growth. On the other hand, selection of suitable substrate material for designing microfluidic chip; difficulty in up-scaling the process for mass production; and product-design and cost related challenges in the developing countries - are recognized as the major hurdles to overcome.

The adoption of LOC/microfluidic diagnostics is expected to grow at the fastest CAGR during the forecast year. This is attributed to its capability to scaling down whole laboratory process on a single chip and expedite the process of disease diagnosis with highly precise quantitative results.

The non-LOC POC technologies segment is estimated to command the largest share of the global microfluidic immunoassay market in 2019. The large share of this segment is attributed to a greater adoption of these technologies - over the years - for wide range of diagnostic applications. However, LOC POC technology is expected to grow at the fastest CAGR during the forecast period. This is mainly attributed to greater benefits offered by LOC over conventional POC diagnostic methods and growing research activities in this field - supported by private and public funding.

On the basis of application, the cardiac biomarker detection segment is estimated to hold the largest share of the global microfluidic immunoassay market in 2019 and is poised to grow at the fastest CAGR during the forecast period. The large share this segment is attributed to high prevalence of cardiovascular diseases, availability of large number of LOC-based products for cardiac biomarkers, and relatively greater adoption of these products among end-users.

An in-depth analysis of the geographical scenario of the microfluidic immunoassay market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global microfluidic immunoassay market in 2019, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa.

The key players operating in the global microfluidic immunoassay market are Abaxis, Inc. (a subsidiary of Zoetis Inc.), Nanōmix, Inc., Abbott Laboratories, Koninklijke Philips N.V., Biosurfit SA, Micropoint Bioscience, Inc., Siloam Biosciences, NanoEnTek Inc., OPKO Health, Inc., and Quidel Corporation.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biosurfit SA
  • Koninklijke Philips N.V.
  • NanoEnTek Inc.
  • Nanomix Inc.
  • OPKO Health Inc.
  • MORE

1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Venture Capital Funding for the Development of LOC-Based POC Diagnostics
4.2.1.2. Rising Prevalence of Chronic Diseases Coupled with Aging Population
4.2.1.3. Greater Benefits offered by Microfluidic/LOC Over Conventional Quantifiable Technologies
4.2.1.4. Rapid Decision Making in Emergency Care
4.2.1.5. Growing Need for POC Testing in Low-Resource Setting
4.2.1.6. Rising Research Activities Related to Microfluidic Technology
4.2.2. Market Restraints
4.2.2.1. Tedious Regulatory Approval Process
4.2.2.2. Reluctance of Healthcare Professionals to Replace the Existing Diagnostic Platforms
4.2.3. Market Opportunities
4.2.3.1. Significant Opportunities from Emerging Economies
4.2.3.2. Emerging Technologies Such as Paper-Based Microfluidics - offers New Growth Avenues
4.2.4. Market Challenges
4.2.4.1. Selection of Suitable Substrate Material for Designing Microfluidic Chip
4.2.4.2. Product-Design and Cost Related Challenges in the Developing Countries
4.3. Supply Chain Analysis
4.4. Market Share Analysis
4.5. Regulatory Analysis
4.5.1. North America
4.5.2. Europe
4.5.3. Asia-Pacific
4.5.4. Latin America, Middle East & Africa
4.6. Pricing Analysis
4.6.1. Cost Comparison: POC Tests Vs Central Lab Test
4.6.2. Pricing Trend for Microfluidic Tests
4.6.3. Single Analyte Testing Vs Multiple Analyte Testing (Panel Testing) in Microfluidic Detection

5. Quantitative POC Immunoassay Diagnostics Market, by Product Type
5.1. Introduction
5.2. Lab-On-Chip/Microfluidic Diagnostics
5.2.1. Microfluidic Analyzers
5.2.2. Microfluidic Cartridges
5.3. Other Quantifiable Point of Care Diagnostics
5.3.1. POC Analyzers
5.3.2. Reagents and Assays

6. Quantitative Point of Care Clinical Immunoassay Diagnostics Market, by Technology ($Value)
6.1. Introduction
6.2. Point-of-Care Lab-On-Chip Technology
6.2.1. Electrochemical LOC POC Technology
6.2.2. Optical Point-of-Care Lab-On-Chip Technology
6.3. Quantitative Non-LOC POC Technology

7. Microfluidic POC Immunoassay Diagnostics Market, by Application ($Value)
7.1. Introduction
7.2. Cardiac Biomarker Detection
7.2.1. Single Biomarker Assay
7.2.1.1. Troponin
7.2.1.2. Brain Natriuretic Peptide (BNP)
7.2.1.3. Other Cardiac Biomarkers
7.2.2. Multiplexed (Panel) Assay
7.3. Inflammatory Biomarker Detection
7.4. Other Biomarkers
7.5. Emerging Biomarkers

8. Geographic Analysis
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe (RoE)
8.4. Asia-Pacific (APAC)
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Rest of Asia Pacific (RoAPAC)
8.5. Rest of the World (RoW)
8.5.1. Latin America (LATAM)
8.5.2. Middle East and Africa

9. Competitive Landscape
9.1. Competitive Benchmarking
9.2. Quantitative POC Immunoassay Diagnostics Products

10. Company Profiles
10.1. Abaxis, Inc. (A Subsidiary of Zoetis Inc.)
10.1.1. Business Overview
10.1.2. Financial Overview
10.1.3. Product Portfolio
10.1.4. Strategic Developments
10.2. Nanomix, Inc.
10.2.1. Business Overview
10.2.2. Financial Overview
10.2.3. Product Portfolio
10.2.4. Strategic Developments
10.3. Abbott Laboratories (Including Alere)
10.3.1. Business Overview
10.3.2. Financial Overview
10.3.3. Product Portfolio
10.3.4. Strategic Developments
10.4. Koninklijke Philips N.V.
10.4.1. Business Overview
10.4.2. Financial Overview
10.4.3. Product Portfolio
10.4.4. Strategic Developments
10.5. Biosurfit Sa
10.5.1. Business Overview
10.5.2. Financial Overview
10.5.3. Product Portfolio
10.5.4. Strategic Developments
10.6. Micropoint Bioscience, Inc.
10.6.1. Business Overview
10.6.2. Financial Overview
10.6.3. Product Portfolio
10.6.4. Strategic Developments
10.7. Siloam Biosciences, Inc.
10.7.1. Business Overview
10.7.2. Financial Overview
10.7.3. Product Portfolio
10.7.4. Strategic Developments
10.8. NanoEnTek Inc.
10.8.1. Business Overview
10.8.2. Financial Overview
10.8.3. Product Portfolio
10.8.4. Strategic Developments
10.9. Opko Health, Inc.
10.9.1. Business Overview
10.9.2. Financial Overview
10.9.3. Product Portfolio
10.9.4. Strategic Developments
10.10. Quidel Corporation
10.10.1. Business Overview
10.10.2  Financial Overview
10.10.3. Product Portfolio
10.10.4. Strategic Developments

11. Appendix
11.1. Industry Speaks

List of Tables
Table 1 Global Quantitative POC Clinical Immunoassay Diagnostics Market Drivers: Impact Analysis
Table 2 Global Quantitative POC Clinical Immunoassay Diagnostics Market Restraints: Impact Analysis
Table 3 Raw Material Suppliers for LOC POC Devices
Table 4 Contract Manufacturing Organizations (CMO) for LOC POC Devices
Table 5 OEMS for LOC POC Devices
Table 6 End-Users for LOC POC Devices
Table 7 Policy/Guidelines/Standards for POCT Devices in Europe
Table 8 POC Regulations in Asia-Pacific
Table 9 POC Regulations in Rest of the World
Table 10 Cost Comparison: LOC POC Test Vs Central Lab Test
Table 11 Price Comparison: Single and Multiple Analyte Tests
Table 12 Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017-2025 ($Million)
Table 13 Global Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017-2025 ($Million)
Table 14 Global Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017-2025 (Thousand Units)
Table 15 Global Lab-On-Chip/ Microfluidic Diagnostics Market Size, by Country/Region, 2017-2025 ($Million)
Table 16 Examples of Microfluidic-Based Analyzers
Table 17 Global Microfluidic Analyzers Market Size, by Country/Region, 2017-2025 ($Million)
Table 18 Global Microfluidic Analyzers Market Size, by Country/Region, 2017-2025 (Thousand Units)
Table 19 Advantages and Limitations of Substrate Materials
Table 20 Examples of Commercially Available Microfluidic-Based Cartridges
Table 21 Global Cartridges Market Size, by Country/Region, 2017-2025 ($Million)
Table 22 Global Microfluidic Cartridges Market Size, by Country/Region, 2017-2025 (Thousand Units)
Table 23 Global Other Quantifiable Point of Care Diagnostics Market Size, by Type, 2017-2025 ($Million)
Table 24 Global Other Quantifiable Point of Care Diagnostics Market Size, by Country/Region, 2017-2025 ($Million)
Table 25 Examples of Commercially Available POC Analyzers
Table 26 Global Market Size for Other POC Analyzers, by Country/Region, 2017-2025 ($Million)
Table 27 Examples of Commercially Available Non-LOC POC Assays
Table 28 Global Reagents and Assays Market Size, by Country/Region, 2017-2025 ($Million)
Table 29 Quantitative Point of Care Immunoassay Diagnostics Market, by Technology, 2017-2025 ($Million)
Table 30 Detection Technologies Used in Commercial Microfluidic POC Devices
Table 31 Global LOC POC Technology Market Size, by Type, 2017-2025 ($Million)
Table 32 Global LOC POC Technology Market Size, by Country/Region, 2017-2025 ($Million)
Table 33 Global Electrochemical LOC POC Technology Market Size, by Country/Region, 2017-2025 ($Million)
Table 34 OPTO-Microfluidic Detection Methods
Table 35 Global Optical LOC POC Technology Market Size, by Country/Region, 2017-2025 ($Million)
Table 36 Technologies Used in Commercial Quantitative Non-LOC POC Devices
Table 37 Global Non-LOC Point of Care Technology Market Size, by Country/Region, 2017-2025 ($Million)
Table 38 Global Quantitative POC Immunoassay Diagnostics Market Size, by Application, 2017-2025 ($Million)
Table 39 Global Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 40 Global Microfluidic POC Market Size for Cardiac Biomarkers, by Country/Region, 2017-2025 ($Million)
Table 41 Commercially Available Tests for Single Cardiac Biomarker Detection
Table 42 Global Microfluidic POC Market Size for Single Biomarker Assay, by Type, 2017-2025 ($Million)
Table 43 Global Microfluidic POC Market Size for Single Cardiac Biomarker Assay, by Country/Region, 2017-2025 ($Million)
Table 44 Global Microfluidic POC Market Size for Troponin Assay, by Country/Region, 2017 – 2025 ($Million)
Table 45 Global Microfluidic POC Market Size for BNP Assays, by Country/Region, 2017 – 2025 ($Million)
Table 46 Global Microfluidic POC Market Size for Other Cardiac Biomarkers, by Country/Region, 2017 – 2025 ($Thousand)
Table 47 Commercially Available Tests for Multiplexed Cardiac Assays
Table 48 Global Microfluidic POC Market Size for Multiplexed Cardiac Assay, by Country/Region, 2017-2025 ($Million)
Table 49 Global Microfluidic POC Market Size for inflammatory Biomarkers, by Country/Region, 2017-2025 ($Million)
Table 50 Tests/Devices for Hba1c and Glucose Detection
Table 51 Clinically Significant Tumor Markers
Table 52 Global LOC POC Immunodiagnostics Market Size for Other Biomarkers, by Country/Region, 2017-2025 ($Thousand)
Table 53 Emerging Biomarkers
Table 54 Global POC Immunoassay Diagnostics Market Size, by Country/Region, 2017-2025 ($Million)
Table 55 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2017 – 2025 ($Million)
Table 56 North America: Microfluidic POC Immunoassay Diagnostics Market, by Country, 2017 – 2025 ($Million)
Table 57 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 58 North America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 59 North America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 60 North America: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 61 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 62 North America: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 63 North America: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 64 North America: Microfluidic POC Market size for Cardiac Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 65 North America: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 66 U.S.: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 67 U.S.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 68 U.S.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 69 U.S.: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 70 U.S.: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 71 U.S.: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 72 U.S.: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 73 U.S.: Microfluidic POC Market size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 74 U.S.: Microfluidic POC Market Size for Single Cardiac Biomarker, by Type, 2017 – 2025 ($Million)
Table 75 Canada: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 76 Canada: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 77 Canada: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 78 Canada: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 79 Canada: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 80 Canada: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 81 Canada: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 82 Canada: Microfluidic POC Market Size for Cardiac Biomarkers, by Type, 2017 – 2025 ($Million)
Table 83 Canada: Microfluidic POC Market Size for Single Biomarker, by Type, 2017 – 2025 ($Million)
Table 84 Europe: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2017-2025 ($Million)
Table 85 Europe: Microfluidic POC Immunoassay Diagnostics Market Size, by Country, 2017 – 2025 ($Million)
Table 86 Europe: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 87 Europe: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 88 Europe: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 89 Europe: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 90 Europe:  Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 91 Europe: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 92 Europe: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 93 Europe: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 94 Europe: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 95 Germany: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 96 Germany: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 97 Germany: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 98 Germany: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 99 Germany: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 100 Germany: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 101 Germany: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 102 Germany: Microfluidic POC Market Size for Cardiac Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 103 Germany: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 104 France: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 105 France: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 106 France: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 107 France: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 108 France: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 109 France: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 110 France: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 111 France: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 112 France: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 113 U.K.: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 114 U.K.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 115 U.K.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 116 U.K.: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 117 U.K.: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 118 U.K.: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 119 U.K.: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 120 U.K.: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 121 U.K.: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 122 Italy: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 123 Italy: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 124 Italy: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 125 Italy: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 126 Italy: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 127 Italy: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Thousand)
Table 128 Italy: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 129 Italy: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 130 Italy: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 131 Spain: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 132 Spain: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 133 Spain: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 134 Spain: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 135 Spain: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 136 Spain: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 137 Spain: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 138 Spain: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 139 Spain: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 140 RoE: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 141 RoE: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 142 RoE: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 143 RoE: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 144 RoE: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 145 RoE: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 146 RoE: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 147 RoE: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 148 RoE: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 149 APAC: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2017-2025 ($Million)
Table 150 APAC: Microfluidic POC Immunoassay Diagnostics Market, by Country, 2017 – 2025 ($Million)
Table 151 APAC: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 152 APAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 153 APAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 154 APAC: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 155 APAC: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 156 APAC: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 157 APAC: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 158 APAC: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 159 APAC: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 160 Japan: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 161 Japan: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 162 Japan: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 163 Japan: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 164 Japan: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 165 Japan: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 166 Japan: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 167 Japan: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 168 Japan: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 169 China: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 170 China: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 171 China: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 172 China: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 173 China: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 174 China: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 175 China: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 176 China: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 177 China: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 178 India: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 179 India: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 180 India: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 181 India: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 182 India: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 183 India: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 184 India: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 185 India: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 186 India: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 187 RoAPAC: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 188 RoAPAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 189 RoAPAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 190 RoAPAC: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 191 RoAPAC: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 192 RoAPAC: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 193 RoAPAC: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 194 RoAPAC: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 195 RoAPAC: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 196 RoW: Quantitative POC Immunoassay Diagnostics Market, by Region, 2017-2025 ($Million)
Table 197 RoW: Microfluidic POC Immunoassay Diagnostics Market, by Region, 2017 – 2025 ($Million)
Table 198 RoW: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 199 RoW: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 200 RoW: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 201 RoW: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 202 RoW: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 203 RoW: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 204 RoW: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 205 RoW: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 206 RoW: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 207 Latin America: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 208 Latin America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 209 Latin America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 210 Latin America: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 211 Latin America: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 212 Latin America: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 213 Latin America: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 214 Latin America: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 215 Latin America: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 216 Middle East & Africa: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 217 Middle East & Africa: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 218 Middle East & Africa: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 219 Middle East & Africa: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 220 Middle East & Africa: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 221 Middle East & Africa: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Thousand)
Table 222 Middle East & Africa: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 223 Middle East & Africa: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 224 Middle East & Africa: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 225 Number of Developments by the Major Players During 2016-2019
Table 226 Quantitative POC Immunoassay Diagnostics: Competitive Benchmarking
Table 227 Key Products: Quantitative POC Immunoassay Diagnostics

List of Figures
Figure 1 Research Process
Figure 2 Key Executives interviewed
Figure 3 Market Size Estimation of LOC POC Immunodiagnostics Market
Figure 4 Market Size Estimation of Other Quantifiable POC Immunodiagnostics Market
Figure 5 Market Size Estimation of Total POC Immunoassay Market
Figure 6 Key Opportunities
Figure 7 Key Adopters of Microfluidic POC Clinical Immunoassay Diagnostics
Figure 8 LOC POC Technology Will Grow Fastest and Surpass Other Quantifiable POC Immunoassay Diagnostics Market by 2025
Figure 9 Quantitative POC Immunoassay Diagnostics Market Overview: 2019-2025
Figure 10 Global LOC POC Immunoassay Diagnostics Market, by Geography, 2018
Figure 11 Number of Cancer Cases Across the World (In Millions)
Figure 12 Prevalence of Diabetes, by Region, 2003 & 2025
Figure 13 Number of Deaths Attributed to Cardiovascular Diseases (Global), 2013-2030 (In Millions)
Figure 14 Disposable Personal income in China (In USD)
Figure 15 Supply Chain Analysis for LOC POC Immunoassay Diagnostics Market
Figure 16 Global Microfluidic POC Immunoassay Diagnostic Market Share, by Key Players, 2018
Figure 17 Pricing Trend for LOC-Based Diagnostic Test for the U.S. and China: 2017-2025
Figure 18 Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2019-2025 ($Million)
Figure 19 Quantitative Point of Care Clinical Immunoassay Diagnostics Market, by Technology, 2019-2025 ($Million)
Figure 20 Global Quantitative POC Immunoassay Diagnostics Market Size, by Application, 2019-2025 ($Million)
Figure 21 Global POC Immunoassay Diagnostics Market Size, by Region, 2019-2025 ($Million)
Figure 22 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 23 North America: Microfluidic POC Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 24 Europe: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 25 Europe: Microfluidic POC Clinical Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 26 Percentage of Older People (65 Years and Above) in France, 2000-2050
Figure 27 U.K.: Proportional Mortality, by Disease Type, 2014
Figure 28 Proportion of Elderly Population in Poland, 2000-2030 (%)
Figure 29 APAC: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 30 APAC: Microfluidic POC Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 31 Japan: Proportional Mortality, 2014
Figure 32 China Population Growth Chart, 2010-2040
Figure 33 RoW: Quantitative POC Immunoassay Diagnostics Market, by Region, 2019-2025 ($Million)
Figure 34 RoW: Microfluidic POC Immunoassay Diagnostics Market, by Region, 2019-2025 ($Million)
Figure 35 Latin America: Aging Population, 2005-2050
Figure 36 Growth Strategies Adopted by Key Players
Figure 37 Zoetis Inc.: Financial Overview (2016-2018)
Figure 38 Abbott Laboratories: Financial Overview (2016-2018)
Figure 39 Koninklijke Philips N.V.: Financial Overview (2016-2018)
Figure 40 NanoEnTek, Inc: Financial Overview (2015-2017)
Figure 41 Opko Health, Inc.: Financial Overview (2016-2018)
Figure 42 Quidel Corporation: Financial Overview (2016-2018)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abaxis Inc. (a subsidiary of Zoetis Inc.)
  • Abbott Laboratories
  • Biosurfit SA
  • Koninklijke Philips N.V.
  • Micropoint Bioscience Inc.
  • NanoEnTek Inc.
  • Nanōmix Inc.
  • OPKO Health Inc.
  • Quidel Corporation
  • Siloam Biosciences
Note: Product cover images may vary from those shown
Adroll
adroll